Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Zymeworks Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results"
06/12/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Elimination of Series B Participating Preferred Stock of Zymeworks Inc",
"Certificate of Elimination of Series B Participating Preferred Stock of Zymeworks Inc"
05/18/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Separation Agreement and Release by and between Zymeworks BC Inc. and Neil Klompas",
"Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer"
05/16/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Amended and Restated License and Collaboration Agreement, by and between Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Limited"
05/08/2023 8-K Quarterly results
Docs: "Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results"
04/26/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
03/17/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/15/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Amended and Restated Bylaws of Zymeworks Inc",
"Amended and Restated Bylaws of Zymeworks Inc"
03/07/2023 8-K Quarterly results
Docs: "Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results"
01/19/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
01/04/2023 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023"
12/30/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to Employment Agreement, by and among Kenneth Galbraith, Zymeworks BC Inc. and Zymeworks Management Inc",
"Amendment to Employment Agreement, by and among Kenneth Galbraith, Zymeworks BC Inc. and Zymeworks Management Inc"
12/21/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab"
12/19/2022 8-K Quarterly results
12/19/2022 8-K Quarterly results
12/09/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "New Clinical Data for Zanidatamab in HER2+ /HR+ Metastatic Breast Cancer Presented Today at 2022 SABCS"
12/05/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Zymeworks to Transfer Stock Listing to Nasdaq"
11/29/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Zymeworks Announces Expiration of Hart-Scott-Rodino Waiting Period for Zanidatamab License Agreement with Jazz Pharmaceuticals"
11/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to Amended and Restated Employment Agreement, by and between Christopher Astle and Zymeworks BC Inc.",
"Amendment to Amended and Restated Employment Agreement, by and between Christopher Astle and Zymeworks BC Inc."
11/09/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Sales Agreement, by and between Zymeworks Inc. and Cantor Fitzgerald & Co",
"Legal Opinion of Wilson Sonsini Goodrich & Rosati, P.C"
11/08/2022 8-K Quarterly results
Docs: "Zymeworks Provides Corporate Update and Reports Third Quarter 2022 Financial Results"
10/28/2022 8-K Quarterly results
10/21/2022 8-K Quarterly results
10/19/2022 8-K Quarterly results
10/13/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation",
"Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy